Follitropin Delta

6 trials 3 recruiting GUrology & Gynaecology

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

1 Completed trials

4 Sponsors

7 Countries

Phase II

Phase III/IV

Phase IV

Phase II: 2 Phase III/IV: 1 Phase IV: 3

Indications tested

Infertility 1 Infertility female 1

Sponsors using this IMP

Ferring Pharmaceuticals A/S 2 Santiago Dexeus Font Fundacio Privada 2 Centre Hospitalier Intercommunal Creteil 1 Universitair Ziekenhuis Brussel 1

All trials

6 total

MENOPUR and REKOVELLE in Women UnderGoing an assisted reproductive technology cycle Pending

2022-500308-23-00 Phase III/IV 2 countries Ferring Pharmaceuticals A/S
The impact of ovarian stimulation with hMG on embryo quality in advanced age women. A randomized controlled trial Pending

2025-524761-25-00 Phase IV 1 country Santiago Dexeus Font Fundacio Privada
Using a fixed dosage of follitropin delta for ovarian stimulation for intrauterine insemination. Recruiting

2025-520681-22-00 Phase II 1 country Centre Hospitalier Intercommunal Creteil
INtensity of OVarian stimualtion and Euploid Embryos (INOVEE Study) Recruiting

2023-507028-22-00 Phase IV 1 country Santiago Dexeus Font Fundacio Privada
Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone Recruiting

2024-513998-48-00 Phase IV 1 country Universitair Ziekenhuis Brussel
A trial to compare efficacy and safety of follitropin delta versus placebo (inactive treatment) in the treatment of men with idiopathic infe… Ended

2023-508430-34-00 Phase II 6 countries Ferring Pharmaceuticals A/S

Showing 1–6 of 6 trials

← All drugs A–Z